Schedule 13D ownership disclosure

CARISMA THERAPEUTICS INC

Common Stock, $0.001 par value per share · CUSIP: 14216R101

Event date: 2025-09-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • HealthCap VII, L.P.Reported CIK 0001645161

    Shares: 0 · Class: 0.0%

  • HealthCap VII GP LLC

    Shares: 0 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-112500
Form type
SCHEDULE 13D/A
Filer
Carisma Therapeutics Inc.
CIK
CIK 1485003
Filed
Sep 02, 2025
Reporting period
Sep 02, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub